Dr. Erin Doty, MD

NPI: 1790866747
Total Payments
$71,947
2024 Payments
$33.86
Companies
36
Transactions
168

Payment Breakdown by Category

Consulting$23,475 (32.6%)
Other$22,347 (31.1%)
Travel$14,191 (19.7%)
Research$7,506 (10.4%)
Food & Beverage$4,429 (6.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $23,475 9 32.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,347 12 31.1%
Travel and Lodging $14,191 34 19.7%
Unspecified $7,506 11 10.4%
Food and Beverage $4,429 102 6.2%

Payments by Type

General
$64,441
157 transactions
Research
$7,506
11 transactions

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $18,483 25 $0 (2018)
Allergan Inc. $17,691 34 $0 (2018)
Eli Lilly and Company $14,019 9 $0 (2019)
Lilly USA, LLC $12,551 23 $0 (2018)
Sun Pharmaceutical Industries Inc. $3,748 6 $0 (2017)
Teva Pharmaceuticals USA, Inc. $3,695 14 $0 (2018)
Promius Pharma LLC $654.74 4 $0 (2018)
Eisai Inc. $138.86 2 $0 (2023)
Neurocrine Biosciences, Inc. $108.28 1 $0 (2017)
Genentech USA, Inc. $96.15 4 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $33.86 2 ABBVIE INC. ($33.86)
2023 $135.34 2 Eisai Inc. ($121.96)
2022 $53.19 1 Genentech USA, Inc. ($53.19)
2021 $11.59 1 AbbVie Inc. ($11.59)
2019 $3,889 3 Eli Lilly and Company ($3,850)
2018 $29,973 78 Amgen Inc. ($10,926)
2017 $37,851 81 Allergan Inc. ($13,103)

All Payment Transactions

168 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
07/25/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $18.76 General
Category: NEUROSCIENCE
02/07/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $15.10 General
Category: NEUROSCIENCE
07/10/2023 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $13.38 General
Category: NEUROSCIENCE
04/22/2023 Eisai Inc. Leqembi (Drug) Food and Beverage Cash or cash equivalent $121.96 General
Category: Neurology
08/01/2022 Genentech USA, Inc. Food and Beverage In-kind items and services $53.19 General
10/15/2021 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $11.59 General
Category: NEUROSCIENCE
04/02/2019 Eli Lilly and Company Consulting Fee Cash or cash equivalent $3,850.00 General
03/08/2019 TerSera Therapeutics LLC PRIALT (Drug) Food and Beverage In-kind items and services $19.56 General
Category: PAIN
03/06/2019 TerSera Therapeutics LLC PRIALT (Drug) Food and Beverage In-kind items and services $19.56 General
Category: PAIN
12/10/2018 Lilly USA, LLC Food and Beverage In-kind items and services $48.14 General
06/26/2018 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $6.59 General
Category: Neuroscience
06/21/2018 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Neuroscience
06/19/2018 Egalet US Inc SPRIX (Drug) Food and Beverage In-kind items and services $16.55 General
Category: Pain Medicine
06/14/2018 Allergan Inc. BOTOX THERAPEUTIC (Biological) Food and Beverage In-kind items and services $12.53 General
Category: HYPERHYDROSIS
06/12/2018 Lilly USA, LLC AMYVID (Drug) Food and Beverage In-kind items and services $15.56 General
Category: Neuroscience
05/31/2018 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $26.72 General
Category: Neuroscience
05/25/2018 Allergan Inc. BOTOX THERAPEUTIC (Biological) Food and Beverage In-kind items and services $10.70 General
Category: HYPERHYDROSIS
05/22/2018 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $18.51 General
Category: AUTOIMMUNE AND RARE DISEASE
05/15/2018 Assertio Therapeutics, Inc. Cambia (Drug), Gralise, Zipsor Food and Beverage In-kind items and services $10.78 General
Category: Neurology
05/11/2018 Allergan Inc. BOTOX THERAPEUTIC (Biological) Food and Beverage In-kind items and services $5.89 General
Category: HYPERHYDROSIS
05/08/2018 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $15.46 General
Category: AED
05/01/2018 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $19.49 General
Category: NEUROLOGY
04/30/2018 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $11.47 General
Category: AUTOIMMUNE AND RARE DISEASE
04/24/2018 Avanir Pharmaceuticals, Inc. ONZETRA Xsail (Drug) Food and Beverage In-kind items and services $16.85 General
Category: Migraine
04/17/2018 Teva Pharmaceuticals USA, Inc. COPAXONE (Drug) Food and Beverage In-kind items and services $11.16 General
Category: Central Nervous System

Research Studies & Clinical Trials

Study Name Company Amount Records
Sun Pharma Research Sun Pharmaceutical Industries Inc. $3,748 6
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA Eli Lilly and Company $1,692 1
A PHASE 23, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION. Allergan Inc. $1,491 3
ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE Eli Lilly and Company $575.83 1

About Dr. Erin Doty, MD

Dr. Erin Doty, MD is a Neurology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790866747.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Doty, MD has received a total of $71,947 in payments from pharmaceutical and medical device companies, with $33.86 received in 2024. These payments were reported across 168 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($23,475).

Practice Information

  • Specialty Neurology
  • Location Jacksonville, FL
  • Active Since 10/18/2006
  • Last Updated 04/09/2010
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1790866747

Products in Payments

  • BOTOX (Biological) $12,851
  • Odomzo (Drug) $3,650
  • BOTOX CHRONIC MIGRAINE (Drug) $3,122
  • Zembrace (Drug) $654.74
  • Aimovig (Biological) $158.31
  • Leqembi (Drug) $121.96
  • INGREZZA (Drug) $108.28
  • Absorica (Drug) $97.50
  • BOTOX THERAPEUTIC (Biological) $87.08
  • TROKENDI XR (Drug) $75.49
  • NAMZARIC (Drug) $49.57
  • AMPYRA (Drug) $46.78
  • OCREVUS (Biological) $42.96
  • PRIALT (Drug) $39.12
  • AUBAGIO (Drug) $34.70
  • ONZETRA Xsail (Drug) $34.62
  • UBRELVY (Drug) $33.86
  • AMYVID (Drug) $30.54
  • ACTHAR (Biological) $29.98
  • SOLIRIS (Drug) $29.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Jacksonville